Sandy Spring Bank’s Fulgent Genetics FLGT Stock Holding History

Sandy Spring Bank’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-168	Closed	-$4.86K	–	1264
2023 Q4	$4.86K	Hold	168	–	–	﹤0.01%	916
2023 Q3	$4.49K	Hold	168	–	–	﹤0.01%	936
2023 Q2	$6.22K	Hold	168	–	–	﹤0.01%	923
2023 Q1	$5.25K	Sell	168 -200	-54%	-$6.44K	﹤0.01%	924
2022 Q4	$11K	Sell	368 -168	-31%	-$6.01K	﹤0.01%	803
2022 Q3	$21K	Buy	536 +200	+60%	+$10K	﹤0.01%	663
2022 Q2	$18K	Hold	336	–	–	﹤0.01%	716
2022 Q1	$21K	Hold	336	–	–	﹤0.01%	700
2021 Q4	$34K	Hold	336	–	–	﹤0.01%	654
2021 Q3	$30K	Hold	336	–	–	﹤0.01%	672
2021 Q2	$31K	Hold	336	–	–	﹤0.01%	681
2021 Q1	$32K	Buy	336 +140	+71%	+$14.5K	﹤0.01%	593
2020 Q4	$10K	Buy	+196	New	+$8.19K	﹤0.01%	749

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sandy Spring Bank's FLGT Position: Q1 2024 in Review

Sandy Spring Bank sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 168 shares — an estimated $4.86K sold.

Sandy Spring Bank first reported a position in FLGT in Q4 2020 and held it in 13 quarters. The position peaked at $34K in Q4 2021. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

Sandy Spring Bank reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
Sandy Spring Bank sold 168 Fulgent Genetics shares in Q1 2024, an estimated $4.86K.
Sandy Spring Bank first reported a position in Fulgent Genetics in Q4 2020 and held it in 13 quarters.
Sandy Spring Bank's Fulgent Genetics position peaked at $34K in Q4 2021.
180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Sandy Spring Bank's 13F filing for Q1 2024, filed 8 May 2024.